Purple Biotech Ltd (PPBT)
0.5128
+0.01
(+2.56%)
USD |
NASDAQ |
May 16, 16:00
0.5128
0.00 (0.00%)
After-Hours: 20:00
Purple Biotech Price to Book Value: 0.3981 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 0.3882 |
| May 14, 2024 | 0.396 |
| May 13, 2024 | 0.4037 |
| May 10, 2024 | 0.4077 |
| May 09, 2024 | 0.411 |
| May 08, 2024 | 0.4268 |
| May 07, 2024 | 0.396 |
| May 06, 2024 | 0.4079 |
| May 03, 2024 | 0.4115 |
| May 02, 2024 | 0.42 |
| May 01, 2024 | 0.4061 |
| April 30, 2024 | 0.403 |
| April 29, 2024 | 0.396 |
| April 26, 2024 | 0.3804 |
| April 25, 2024 | 0.4006 |
| April 24, 2024 | 0.3981 |
| April 23, 2024 | 0.3804 |
| April 22, 2024 | 0.352 |
| April 19, 2024 | 0.3533 |
| April 18, 2024 | 0.3579 |
| April 17, 2024 | 0.3372 |
| April 16, 2024 | 0.32 |
| April 15, 2024 | 0.453 |
| April 12, 2024 | 0.4769 |
| April 11, 2024 | 0.4775 |
| Date | Value |
|---|---|
| April 10, 2024 | 0.5328 |
| April 09, 2024 | 0.5551 |
| April 08, 2024 | 0.5551 |
| April 05, 2024 | 0.5435 |
| April 04, 2024 | 0.5435 |
| April 03, 2024 | 0.5485 |
| April 02, 2024 | 0.5238 |
| April 01, 2024 | 0.5346 |
| March 28, 2024 | 0.5202 |
| March 27, 2024 | 0.4744 |
| March 26, 2024 | 0.4828 |
| March 25, 2024 | 0.4856 |
| March 22, 2024 | 0.521 |
| March 21, 2024 | 0.5217 |
| March 20, 2024 | 0.505 |
| March 19, 2024 | 0.5507 |
| March 18, 2024 | 0.5512 |
| March 15, 2024 | 0.5628 |
| March 14, 2024 | 0.5398 |
| March 13, 2024 | 0.5521 |
| March 12, 2024 | 0.5714 |
| March 11, 2024 | 0.5959 |
| March 08, 2024 | 0.6374 |
| March 07, 2024 | 0.6722 |
| March 06, 2024 | 0.6328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.32
Minimum
Apr 16 2024
19.01
Maximum
Jun 25 2020
1.213
Average
0.9926
Median
Mar 08 2023
Price to Book Value Benchmarks
| Compugen Ltd | 2.923 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 3.881 |
| Can Fite Biofarma Ltd | 1.791 |
| BiomX Inc | 5.977 |
Price to Book Value Related Metrics
| Price | 0.5128 |
| Earnings Yield | -177.5% |
| Market Cap | 13.62M |